Skip to main content
. 2021 Jan 1;17(1):134–150. doi: 10.7150/ijbs.50773

Table 2.

Effects of autophagy-related miRNAs on cancer radiotherapy

Effect on autophagy Name Dysregulated Autophagy-related target Effect on radiotherapy Tested cell line (tissue origin) Ref.
Inhibition miR-17-5p up-regulated Beclin 1 radiosensitivity U87 (glioblastoma) 59
miR-21 up-regulated PTEN radiosensitivity Hela, Siha(cervical cancer) 168
miR-23b downregulated ATG12 radiosensitivity BxPC3, PANC-1 (pancreatic cancer) 139
miR-31 downregulated Beclin 1, ATG, DRAM radiosensitivity Primary cultured cells (colorectal cancer) 169
miR-93 up-regulated Beclin 1, ATG5, ATG4B, SQSTM1 radiosensitivity U87 (glioblastoma) 170
miR-101 downregulated STMN1 radioresistance CNE-2, 5-8F (nasopharyngeal carcinoma) 171
miR-129-5p downregulated HMGB1 radiosensitivity MCF-7, MDA-MB-231 , BT549, BT474 (breast cancer) 43
miR-183-5p up-regulated ATG5 radiosensitivity Caco-2 (colon cancer) 172
miR-200c downregulated UBQLN1 radiosensitivity MDA-MB-231, BT549 (breast cacer) 173
miR-214 downregulated ATG12 radiosensitivity SW480, HCT116 (colorectal cancer) 174
miR-216b up-regulated Beclin 1 radioresistance PANC-1 (pancreatic cancer) 175
miR-450a-5p downregulated DUSP10 radioresistance ECA (esophageal cancer) 176
Activation miR-138-5p downregulated EIF4EBP1 radiosensitivity HONE1, HK1 (nasopharyngeal carcinoma) 141
miR-301a/b up-regulated NDRG2 radioresistance LNCaP (prostate cancer) 142
miR-1246 up-regulated mTOR radioresistance A549, PC9 (lung cancer) 177
miR-4673 up-regulated CDK-18 radioresistance SKBR3 (breast cancer) 178